Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis

Yanliang Chen,Hongtao Luo,Ruifeng Liu,Mingyu Tan,Qian Wang,Xun Wu,Tianqi Du,Zhiqiang Liu,Shilong Sun,Qiuning Zhang,Xiaohu Wang
DOI: https://doi.org/10.1186/s13014-023-02264-x
IF: 4.309
2023-05-24
Radiation Oncology
Abstract:Particle therapy, mainly including carbon-ion radiotherapy (CIRT) and proton beam therapy (PBT), has dose distribution advantages compared to photon radiotherapy. It has been widely reported as a promising treatment method for early non-small cell lung cancer (NSCLC). However, its application in locally advanced non-small cell lung cancer (LA-NSCLC) is relatively rare, and its efficacy and safety are inconclusive. This study aimed to provide systematic evidence for evaluating the efficacy and safety of particle therapy for inoperable LA-NSCLC.
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?